BDMD (Baird Medical Investment Holdings) Net Income: $-15.91 Mil (TTM As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BDMD Baird Medical Investment Holdings Ltd BDMD
17 GF Score
Price $1.13
! 7 Warning Signs
View Full Analysis

What is Baird Medical Investment Holdings Net Income?

Baird Medical Investment Holdings BDMD +4.10% 17 Net Income is $-15.91 Mil as of Jun. 2026. GuruFocus rates BDMD with a GF Score™ of 17/100. The stock has 7 warning signs investors should review.

Net Income is the net profit that a company earns after deducting all costs and losses including cost of goods, SGA, DDA, interest expenses, non-recurring items and tax. Baird Medical Investment Holdings's Net Income for the six months ended in Jun. 2026 was $0.01 Mil. Its Net Income for the trailing twelve months (TTM) ended in Jun. 2026 was $-15.91 Mil.

Net Income is linked to the most popular Earnings per Share (Diluted) number. Baird Medical Investment Holdings's Earnings per Share (Diluted) for the six months ended in Jun. 2026 was $0.00.


Baird Medical Investment Holdings  (NAS:BDMD) Net Income Explanation

Net Income is the most widely cited number in reporting a company's profitability. It is linked to the most popular earnings-per-share (EPS) number through:

Baird Medical Investment Holdings's Earnings per Share (Diluted) (EPS) for the quarter that ended in Jun. 2026 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

EPS is most useful for companies that have:

A predictable business
Consistent accounting methods
And few restructurings

The dividend paid to preferred stocks needs to be subtracted from the total net income in the calculation of EPS because common stock holders are not entitled to that part of the net income.


Be Aware

Warren Buffett looks for consistency and upward long term trend. Because of share repurchase it is possible for net earnings trend to differ from EPS trend. He preferred Net Income over EPS. The companies with durable competitive advantage companies report higher % net earnings to total revenues.

Important: If a company is showing net earnings history greater than 20% on total revenues, it is probably benefiting from a long term competitive advantage.

If net earnings is less than 10%, likely to be in a highly competitive business.


Baird Medical Investment Holdings Net Income Related Terms


Baird Medical Investment Holdings Net Income Historical Data

* Premium members only.

The historical data trend for Baird Medical Investment Holdings's Net Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Baird Medical Investment Holdings Net Income Chart

Baird Medical Investment Holdings Annual Data
Trend Dec21 Dec22 Dec23 Dec24 Dec25
Net Income
10.09 12.57 10.55 12.45 -27.28

Baird Medical Investment Holdings Semi-Annual Data
Dec21 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25 Jun26
Net Income Get a 7-Day Free Trial Premium Member Only 4.33 8.12 -11.36 -15.92 0.01
BDMD
17GF Score
Baird Medical Investment Holdings Ltd BDMD
Net Income is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Baird Medical Investment Holdings Net Income Calculation

Net Income is the net profit that a company earns after deducting all costs and losses including cost of goods, SGA, DDA, interest expenses, non-recurring items and tax.

Net Income
= Revenue - Cost of Goods Sold - Selling, General, & Admin. Expense - Research & Development - Depreciation, Depletion and Amortization - Interest Expense - Non Operating Income (NRI) - Tax Expense + Others
= EBITDA - Depreciation, Depletion and Amortization - Interest Expense - Non Operating Income (NRI) - Tax Expense + Others
= Operating Income - Interest Expense - Non Operating Income (NRI) - Tax Expense + Others
= Pre-Tax Income - Tax Expense + Others

Baird Medical Investment Holdings's Net Income for the fiscal year that ended in Dec. 2025 is calculated as

Net Income(A: Dec. 2025 )
= Pre-Tax Income + Tax Provision + Net Income (Discontinued Operations) + Others
=-26.375+-1.166+0+0.263
=-27.28

Baird Medical Investment Holdings's Net Income for the quarter that ended in Jun. 2026 is calculated as

Net Income(Q: Jun. 2026 )
= Pre-Tax Income + Tax Provision + Net Income (Discontinued Operations) + Others
=0.574+-0.561+0+9.8879238130678E-17
=0.01

Net Income for the trailing twelve months (TTM) ended in Jun. 2026 adds up the semi-annually data reported by the company within the most recent 12 months, which was $-15.91 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Net Income →
What does a Net Income of $-15.91 Mil mean?
Baird Medical Investment Holdings (BDMD) has a Net Income of $-15.91 Mil as of Jun. 2026. Net Income is the total earnings after all operating expenses, interest and taxes. View historical data on Baird Medical Investment Holdings and its competitors.
Is Baird Medical Investment Holdings' Net Income too high?
Baird Medical Investment Holdings' current Net Income is $-15.91 Mil. Overall, Baird Medical Investment Holdings has a GF Score™ of 17/100, reflecting its overall financial health beyond just this single metric.
How does Baird Medical Investment Holdings' Net Income compare to TANAF and NSYS?
Baird Medical Investment Holdings' Net Income of $-15.91 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Income for a Medical Devices & Instruments company?
A good Net Income depends on the Medical Devices & Instruments industry context. However, Net Income should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Income mean?
A high Net Income can signal that a stock is expensive relative to its fundamentals. Net Income is the total earnings after all operating expenses, interest and taxes. View historical data on Baird Medical Investment Holdings and its competitors. Baird Medical Investment Holdings's current Net Income is $-15.91 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Baird Medical Investment Holdings stock overvalued right now?
Baird Medical Investment Holdings (BDMD) has a current Net Income of $-15.91 Mil. The current Net Income is $-15.91 Mil. Baird Medical Investment Holdings' overall GF Score™ is 17/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Income calculated?
Net Income is calculated from a company's financial statements. For Baird Medical Investment Holdings (BDMD), the current Net Income is $-15.91 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Baird Medical Investment Holdings Business Description

Address No.15 Rongtong Street, Room 202, 2nd Floor, Baide Building, Building 11, Yuexiu District, Guangzhou, CHN
Baird Medical Investment Holdings Ltd is a specialized healthcare innovator dedicated exclusively to thyroid-related diseases and a microwave ablation (MWA) medical device manufacturer and provider in China. The company combines clinical expertise with technologies to develop non-invasive treatment solutions. Its proprietary MWA medical devices are used for the treatment of benign and malignant tumors, including thyroid nodules, liver cancer, lung cancer, and breast lumps. Its core activities include the development and commercialization of thyroid microwave ablation systems and an active R&D pipeline of AI-integrated robotic systems, integrating hardware, software, and system-based solutions.
17GF Score

Get the complete analysis for BDMD

Net Income is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$1.13
Price